Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$190.52 - $236.72 $567,940 - $705,662
2,981 Added 23.85%
15,482 $3.59 Million
Q1 2024

Aug 22, 2024

SELL
$212.02 - $267.71 $632,031 - $798,043
-2,981 Reduced 19.25%
12,501 $2.7 Million
Q1 2024

May 01, 2024

SELL
$212.02 - $267.71 $545,951 - $689,353
-2,575 Reduced 17.08%
12,501 $2.7 Million
Q4 2023

Aug 22, 2024

BUY
$222.59 - $267.94 $354,140 - $426,292
1,591 Added 11.8%
15,076 $3.9 Million
Q4 2023

Feb 08, 2024

BUY
$222.59 - $267.94 $354,140 - $426,292
1,591 Added 11.8%
15,076 $3.9 Million
Q3 2023

Aug 22, 2024

SELL
$253.3 - $285.89 $505,840 - $570,922
-1,997 Reduced 12.9%
13,485 $3.47 Million
Q3 2023

Nov 09, 2023

BUY
$253.3 - $285.89 $54,966 - $62,038
217 Added 1.64%
13,485 $3.47 Million
Q2 2023

Aug 09, 2023

BUY
$275.25 - $318.06 $995,854 - $1.15 Million
3,618 Added 37.49%
13,268 $3.78 Million
Q1 2023

Apr 26, 2023

BUY
$256.56 - $292.34 $21,294 - $24,264
83 Added 0.87%
9,650 $2.68 Million
Q4 2022

Feb 08, 2023

BUY
$252.44 - $306.72 $281,470 - $341,992
1,115 Added 13.19%
9,567 $2.65 Million
Q3 2022

Nov 03, 2022

BUY
$194.69 - $268.46 $1.65 Million - $2.27 Million
8,452 New
8,452 $2.26 Million
Q2 2021

Aug 11, 2021

SELL
$259.0 - $414.71 $1.83 Million - $2.94 Million
-7,081 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$242.95 - $284.63 $52,720 - $61,764
-217 Reduced 2.97%
7,081 $1.98 Million
Q4 2020

Feb 09, 2021

BUY
$236.26 - $355.63 $1.72 Million - $2.6 Million
7,298 New
7,298 $1.79 Million
Q4 2018

Feb 12, 2019

SELL
$278.5 - $352.75 $194,393 - $246,219
-698 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$293.51 - $383.83 $204,869 - $267,913
698 New
698 $247,000
Q2 2018

Aug 02, 2018

SELL
$257.52 - $306.91 $850,588 - $1.01 Million
-3,303 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$260.13 - $367.91 $11,445 - $16,188
-44 Reduced 1.31%
3,303 $904,000
Q4 2017

Feb 09, 2018

SELL
$307.64 - $344.58 $301,487 - $337,688
-980 Reduced 22.65%
3,347 $1.07 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $1.22 Million - $1.43 Million
4,327
4,327 $1.36 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.